{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:46:11Z","timestamp":1791179171404,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft"},{"name":"BE 1918\/1-1"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.leukres.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T03:30:57Z","timestamp":1376364657000},"page":"1200-1207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"37","author":[{"given":"Bernd","family":"Gruhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Gruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Sonnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.07.016_bib0005","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ejca.2008.11.042","article-title":"Survival of European children and young adults with cancer diagnosed 1995\u20132002","volume":"45","author":"Gatta","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2013.07.016_bib0010","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2013.07.016_bib0015","doi-asserted-by":"crossref","first-page":"148046","DOI":"10.1155\/2011\/148046","article-title":"The role of HDACs inhibitors in childhood and adolescence acute leukemias","volume":"2011","author":"Masetti","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.leukres.2013.07.016_bib0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/annonc\/mdn792","article-title":"HDAC inhibitor-based therapies and haematological malignancy","volume":"20","author":"Stimson","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2013.07.016_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2010.02.010","article-title":"Histone deacetylases and epigenetic therapies of hematological malignancies","volume":"62","author":"Mercurio","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.leukres.2013.07.016_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc2765","article-title":"Leukaemogenesis: more than mutant genes","volume":"10","author":"Chen","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2013.07.016_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.07.016_bib0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/leu.2011.278","article-title":"Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia","volume":"26","author":"Stumpel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.07.016_bib0050","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1182\/blood-2012-01-401687","article-title":"Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia","volume":"119","author":"Bhatla","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.016_bib0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2009.02.028","article-title":"HDACi \u2013 targets beyond chromatin","volume":"280","author":"Buchwald","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2013.07.016_bib0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2009.02.013","article-title":"Isoform-specific histone deacetylase inhibitors: the next step","volume":"280","author":"Balasubramanian","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2013.07.016_bib0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert W","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2013.07.016_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0075","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1158\/1078-0432.CCR-10-0395","article-title":"HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth","volume":"16","author":"Milde","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2010.08301.x","article-title":"Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia","volume":"150","author":"Moreno","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.07.016_bib0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.2012.09187.x","article-title":"Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents","volume":"158","author":"Sonnemann","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.07.016_bib0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"Dordelmann","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.016_bib0095","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"Moricke","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.016_bib0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.leukres.2013.07.016_bib0110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.lfs.2008.03.004","article-title":"The use of diversity profiling to characterize chemical modulators of the histone deacetylases","volume":"82","author":"Blackwell","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.leukres.2013.07.016_bib0115","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/ijms14023376","article-title":"Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia","volume":"14","author":"Tao","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.leukres.2013.07.016_bib0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2407-10-387","article-title":"Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients","volume":"10","author":"Advani","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.leukres.2013.07.016_bib0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Sjoblom","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.leukres.2013.07.016_bib0130","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-05-4598","article-title":"Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha","volume":"66","author":"Qian","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0135","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1091\/mbc.E08-02-0139","article-title":"HDAC4 promotes growth of colon cancer cells via repression of p21","volume":"19","author":"Wilson","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.leukres.2013.07.016_bib0140","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1158\/0008-5472.CAN-10-4111","article-title":"HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer","volume":"71","author":"Stronach","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/onc.2008.371","article-title":"HDAC4 represses p21(WAF1\/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism","volume":"28","author":"Mottet","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2013.07.016_bib0150","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1158\/0008-5472.CAN-08-2796","article-title":"Loss of histone deacetylase 4 causes segregation defects during mitosis of p53-deficient human tumor cells","volume":"69","author":"Cadot","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.016_bib0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjc.6605895","article-title":"microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity","volume":"103","author":"Zhang","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2013.07.016_bib0160","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.leu.2404282","article-title":"Histone deacetylase inhibitors have antitumor activity in two NOD\/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia","volume":"20","author":"Einsiedel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.07.016_bib0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2013.07.016_bib0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2005.03.002","article-title":"Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia","volume":"7","author":"Lugthart","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.07.016_bib0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.07.016_bib0180","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/leu.2011.388","article-title":"Elevated S100A8\/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia","volume":"26","author":"Spijkers-Hagelstein","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.07.016_bib0185","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.2009.25.9119","article-title":"Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report","volume":"28","author":"Fouladi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.07.016_bib0190","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1182\/blood-2007-10-117150","article-title":"Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"111","author":"Mody","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.016_bib0195","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1021\/jm900555u","article-title":"Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy","volume":"52","author":"Ontoria","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2013.07.016_bib0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.leukres.2013.07.016_bib0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2004.10.024","article-title":"Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis","volume":"1194","author":"Vega","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2013.07.016_bib0210","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2403332","article-title":"Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF","volume":"18","author":"Wellmann","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.07.016_bib0215","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T21:42:38Z","timestamp":1596318158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0145212613002439"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}